Cloning and functional expression of the guinea pig neuropeptide Y Y2 receptor

Regulatory Peptides

Volumn 75-76, Issue , 1998, Pages 23-28

  Sharma, Parul ^a   Holmberg, Sara K s ^a   Eriksson, Henrik ^a   Beck Sickinger, Annette G ^b   Grundemar, Lars ^c   Larhammar, Dan ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b ETH ZURICH   (Switzerland)

^c LUND UNIVERSITY   (Sweden)

Author keywords

7 TM receptor; G protein coupled receptor; NPY derivatives; peptide YY; Pharmacology

Indexed keywords

NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y RECEPTOR; PANCREAS POLYPEPTIDE; PEPTIDE YY; RECEPTOR SUBTYPE; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIOPHAGE; CELL STRAIN COS1; CONTROLLED STUDY; DNA LIBRARY; DRUG RECEPTOR BINDING; GENE EXPRESSION; GUINEA PIG; MOLECULAR CLONING; NONHUMAN; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; ARGININE; CLONING, MOLECULAR; CONSERVED SEQUENCE; COS CELLS; GENE EXPRESSION; GUINEA PIGS; HUMANS; KINETICS; MOLECULAR SEQUENCE DATA; NEUROPEPTIDE Y; PEPTIDE FRAGMENTS; PEPTIDE YY; RATS; RECEPTORS, NEUROPEPTIDE Y; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION;

CAVIA PORCELLUS; MAMMALIA; SUS SCROFA;

EID: 0032566822     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(98)00049-4     Document Type: Article

References (20)

1. Larhammar D. Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide. Regul Pept. 65:1996;165-174.
2. Blomqvist A.G., Herzog H. Y-receptor subtypes - how many more? Trends Neurosci. 20(7):1997;294-298.
3. Lundberg J.M. Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol Rev. 48:1996;113-178.
4. Colmers W.F., Bleakman D. Effects of neuropeptide Y on the electrical properties of neurons. Trends Neurosci. 17:1994;373-379.
5. Potter E., Revington M., Lacroix S.J. Neuropeptide Y Y2 agonist acts as a nasal anti-congestant in humans. Regul Pept. 71(3):1997;214.
6. Playford R.J., Cox H.M. Peptide YY and neuropeptide Y: two peptides intimately involved in electrolyte homeostasis. Trends Pharmacol Sci. 17:1996;436-438.
7. Grundemar L., Jonas S.E., Mörner N., Högestätt E.D., Wahlestedt C., Håkanson R. Characterisation of vascular neuropeptide Y receptors. Br J Pharmacol. 105:1992;45-50.
8. Grundemar L., Ekelund M. Effects of the neuropeptide Y (NPY)-receptor antagonist BIBP3226 on vascular NPY-receptors with different ligand requirements. Pharmacol Toxicol. 79:1996;266-269.
9. Parker L.T., Zakeri H., Deng Q., Spurgeon S., Kwok P.-Y., Nickerson D.A. AmpliTaq® DNA polymerase, FS dye-terminator sequencing: Analysis of peak height patterns. Biotechniques. 21:1996;694-699.
10. Johansen T.E., Schøller M.S., Tolstoy S., Schwartz T.W. Biosynthesis of peptide precursors and protease inhibitors using new constitutive and inducible eukaryotic expression vectors. FEBS Lett. 267:1990;289-294.
11. Lundell I., Blomqvist A.G., Berglund M.M., Schober D.A., Johnson D., Statnick M.A., Gadski R.A., Gehlert D.R., Larhammar D. Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J Biol Chem. 270:1995;29123-29128.
12. Beck A., Jung G., Gaida W., Köppen H., Lang R., Schnorrenberg G. Highly potent and small neuropeptide Y agonist obtained by linking NPY 1-4 via spacer to α-helical NPY 25-36. FEBS Lett. 244(1):1989;119-122.
13. Gehlert D.R., Beavers L., Johnson D., Gackenheimer S.L., Schober D.A., Gadski R.A. Expression cloning of a human brain neuropeptide Y Y2 receptor. Mol Pharmacol. 49:1996;224-228.
14. Rose P.M., Fernandes P., Lynch J.S., Frazier S.T., Fisher S.M., Kodukula K., Kienzle B., Seethala R. Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J Biol Chem. 270:1995;22661-22664.
15. Gerald C., Walker M.W., Vaysse P.J.-J., He C., Branchek T.A., Weinshank R.L. Expression cloning and pharmacological characterization of a human hippocampal neuropeptide Y/peptide YY Y2 receptor subtype. J Biol Chem. 270:1995;26758-26761.
16. Kahl U., Langel U., Bartfai T., Grundemar L. Functional effects and ligand binding of chimeric galanin-neuropeptide Y (NPY) peptides on NPY and galanin receptor types. Br J Pharmacol. 111:1994;1129-1134.
17. Rist B., Zerbe O., Ingenhoven N., Scapozza L., Peers C., Vaughan P.F.T., McDonald R.L., Wieland H.A., Beck-Sickinger A.G. Modified, cyclic dodecapeptide analog of neuropeptide Y is the smallest full agonist at the human Y2 receptor. FEBS Lett. 394:1996;169-173.
18. Rist B., Ingenhoven N., Scapozza L., Schnorrenberg G., Gaida W., Wieland H.A., Beck-Sickinger A.G. The bioactive conformation of neuropeptide Y analogues at the human Y2-receptor. Eur J Biochem. 247:1997;1019-1028.
19. Leban J.J., Heyer D., Landavazo A., Matthews J., Aulabaugh A., Daniels A.J. Novel modified carboxy terminal fragments of neuropeptide Y with high affinity for Y2-type receptors and potent functional antagonism at Y1-type receptor. J Med Chem. 38(7):1995;1150-1157.
20. Beck-Sickinger AG. The importance of various parts of the NPY molecule for receptor recognition. In: Grundemar L, Stephen R, editors. Neuropeptide Y and drug development. London: Academic Press, 1997:107-126.